Skip to main content

Table 4 Multivariable logistic regression analysis in patients with UC

From: Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study

Parameter

OR

95% CI

p-value

 

Clinical remission at week 17 ± 0.5

 Disease duration from initial diagnosis

1

0.1 to 1.01

0.11

ns

 Hb [g/dL]

1.27

1.00 to 1.66

0.06

ns

 Clinical disease activity

0.71

0.52 to 0.95

0.03

*

 First flare treated with corticosteroids

3.38

0.82 to 18.4

0.12

ns

  1. OR odds ratio